Of note, several P2X7R-dependent inflammation markers have been shown to be dysregulated in the blood of epilepsy patients (e.g., IL-1β [121,122], IL-18 [123]), potentially serving as useful surrogate makers of P2X7R activation/inhibition. The gene discussed is IL1B; the disease is epilepsy.